PHASE-I CLINICAL INVESTIGATION OF FLUDARABINE PHOSPHATE BY A LOADING-DOSE AND CONTINUOUS-INFUSION SCHEDULE

被引：27

作者：

LEIBY, JM

GREVER, MR

STAUBUS, AE

NEIDHART, JA

MALSPEIS, L

机构：

[1] OHIO STATE UNIV,CTR COMPREHENS CANC,DIV HEMATOL & ONCOL,COLUMBUS,OH 43210

[2] OHIO STATE UNIV,DIV PHARMACEUT & PHARMACEUT CHEM,COLUMBUS,OH 43210

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1988年 / 80卷 / 06期

关键词：

D O I：

10.1093/jnci/80.6.447

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：447 / 449

页数：3

共 13 条

[1]

BODEY GP, 1974, P AM ASSOC CANC RES, V15, P129

[2]

BROCKMAN RW, 1980, CANCER RES, V40, P3610

[3] BIOLOGIC ACTIVITY OF 9-BETA-D-ARABINOFURANOSYL-2-FLUOROADENINE - METABOLICALLY STABLE ANALOG OF 9-BETA-D-ARABINOFURANOSYLADENINE [J].

BROCKMAN, RW ;

SCHABEL, FM ;

MONTGOMERY, JA .

BIOCHEMICAL PHARMACOLOGY, 1977, 26 (22) :2193-2196

[4]

CHUN HG, 1986, CANCER TREAT REP, V70, P1225

[5]

GREVER MR, 1984, INVEST NEW DRUG, V2, P116

[6]

GREVER MR, 1984, BLOOD S1, V64, P165

[7]

HUTTON JJ, 1984, CANCER RES, V44, P4183

[8] POTENTIAL ANTICANCER AGENTS .40. SYNTHESIS OF THE BETA-ANOMER OF 9-(D-ARABINOFURANOSYL)-ADENINE [J].

LEE, WW ;

BENITEZ, A ;

GOODMAN, L ;

BAKER, BR .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1960, 82 (10) :2648-2699

[9]

LEPAGE GA, 1973, DRUG METAB DISPOS, V1, P756

[10]

MALSPEIS L, 1984, INVEST NEW DRUG, V2, P116

← 1 2 →